The Utility of 99mTc Depreotide Compared with F-18 Fluorodeoxyglucose Positron Emission Tomography and Surgical Staging in Patients with Suspected Non-small Cell Lung Cancer

Chest

Volumn 125, Issue 2, 2004, Pages 494-501

  Kahn, Daniel ^a,b   Menda, Yusuf ^a   Kernstine, Kemp ^a   Bushnell, David ^a   McLaughlin, Kelley ^a   Miller, Sara ^a   Berbaum, Kevin ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

99mTc depreotide; Lung cancer; Positron emission tomography; Scintigraphy

Indexed keywords

DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE F 18; PENTETATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCINTIGRAPHY; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1242276355     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.2.494     Document Type: Article

References (32)

1. Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer 2000; 28:187-202
2. Goldsmith SJ, Kostakoglu L. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. Semin Ultrasound CT MR 2000; 21:129-138
3. Webb WR, Gatsouris S, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiology Diagnostic Oncology Group. Radiology 1992; 182:319-323
4. Farrell MA, McAdams HP, Herndon JE, et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000; 215:886-890
5. Mac Manus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001; 92:886-895
6. Deslauriers J, Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 2000; 117:96S-103S
7. Salathe M, Soler M, Bolliger CT, et al. Transbronchial needle aspiration in routine fiberoptic bronchoscopy. Respiration 1992; 59:5-8
8. Schenk DA, Bower JH, Bryan CL, et al. Transbronchial needle aspiration staging of bronchogenic carcinoma. Am Rev Respir Dis 1986; 134:146-148
9. Kazerooni EA, Lim FT, Mikhail A, et al. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 1996; 198:371-375
10. Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993; 104:997-1002
11. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075-1084
12. Ho I, O'Doherty MJ, Maisey MN. Positron emission tomography in lung cancer. Semin Nucl Med 2002; 32:240-271
13. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716-731
14. Kwekkeboom DJ, Kho GS, Lamberts SW, et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 21:1106-1113
15. Kwekkeboom DJ, Krenning EP, Bakker WH, et al. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med 1991; 32:1845-1848
16. O'Byrne KJ, Carney DN. Somatostatin and the lung. Lung Cancer 1993; 10:151-172
17. 111In-DTPA octreotide scintigraphy. Eur J Cancer 1995; 31A:184-188
18. 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117: 1232-1238
19. Lowe VJ, Hoffman JM, DeLong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776
20. Beahrs OH, Hensen DE, Hutter RVP, et al, eds. American Joint Committee on Cancer. Lung. In: Manual for staging cancer, 4th ed. Philadelphia, PA: Lippincott, 1992;115-121
21. Park BJ, Louie O, Altorki N. Staging and the surgical management of lung cancer. Radiol Clin North Am 2000; 38:545-561
22. McNemar Q. Psychological statistics, 4th ed. New York, NY; Wiley, 1969; 54-58
23. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med 2000; 343:254-261
24. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of PET for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914-919
25. Blum JE, Handmaker H, Rinne NA. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest 1999; 115:224-232
26. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s; meta-analytic comparison of PET and CT. Radiology 1999; 213:530-536
27. Wahl RL, Quint LE, Greenough RL, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective examination. Radiology 1994; 191:371-377
28. Albes JM, Lietzenmayer R, Schott U, et al. Improvement of non-small-cell lung cancer staging by means of positron emission tomography. Thorac Cardiovasc Surg 1999; 47: 42-47
29. Dunagan D, Chin R, McCain T, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001; 119:333-339
30. Hany TF, Steinert HC, Buck A, et al. PET diagnostic accuracy: improvement with in-line PET-CT system; initial results. Radiology 2002; 225:575-581
31. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212:803-809
32. Weder W, Schmid RA, Bruchhaus H. Detection of extrathoracic metastases by PET in lung cancer. Ann Thorac Surg 1998; 66:886-893